(RSV) is a common cause of lower respiratory tract infection (LRTI) and is responsible for a high burden of hospital admission and mortality in children. RSV–LRTI is also associated with long-term ...

Every year, millions of infants are infected by a little-known virus that is the most common cause of respiratory disease in children. Respiratory syncytial virus (RSV) (Fig. 1) causes a spectrum ...

The convergence of genetic engineering and artificial intelligence brings both the potential to revolutionize medicine and ...

GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...

Exposure to air pollution has previously been tied to a variety of adverse health effects, among them increased risk of ...

"Whereas clinical laboratory testing tracks individual cases of infection, sampling and analysis at the wastewater treatment ...

After decades of research, vaccines protecting against respiratory syncytial virus, or RSV, made their debut last year. The highly contagious virus usually causes mild symptoms. But in some cases ...

Symptoms exhibited by patients are similar to those in respiratory syncytial virus-infected patients ... Organization of the human metapneumovirus genome. The genome organization of HMPV compared ...

Fall brings cooler days and more time indoors. This makes it easier for viruses like influenza (flu), COVID-19 and ...

RSV, or respiratory syncytial virus, is a common cause of coughs and colds which can also lead to severe lung infections like pneumonia and infant bronchiolitis – conditions which are highly ...

Respiratory syncytial virus (RSV) infections are the leading cause of viral death in infants, although RSV-related mortality has decreased since the development and approval of prophylactic ...

Respiratory syncytial virus (RSV)-associated acute lower respiratory infection ... these areas and monitoring the effects of novel agents and policy change on the RSV genome. To assess the use of ...